BIOLASE TO PRESENT AT THE THIRD ANNUAL WINTER WONDERLAND BEST IDEAS VIRTUAL INVESTOR CONFERENCE

Rhea-AI Summary

BIOLASE, a leader in dental lasers, will present at the Third Annual Winter Wonderland Best Ideas Virtual Investor Conference from February 21-24, 2023. The presentation is scheduled for February 21 at 2:00 p.m. PT (5:00 p.m. ET), with management hosting one-on-one meetings on February 23-24. This event is an opportunity for investors to learn more about BIOLASE's innovations in dental technology, comprising over 301 patents and 28 patent-pending technologies. For more information or to request an invitation, email angie.wright@issuerdirect.com. The presentation will be accessible via ir.biolase.com.

LAKE FOREST, Calif., Feb. 16, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it has been invited to present at the Third Annual Winter Wonderland Best Ideas Virtual Investor Conference being held February 21–24, 2023. John Beaver, President and Chief Executive Officer, and Jennifer Bright, Chief Financial Officer, will present at the conference and host virtual meetings with institutional investors and analysts throughout the event.

BIOLASE is scheduled to present on Tuesday, February 21, 2023, at 2:00 p.m. PT (5:00 p.m. ET). Management will be available for one-on-one meetings from February 23–24, 2023. The presentation will be webcast live and available for replay at ir.biolase.com.

To receive additional information, request an invitation, or schedule a one-on-one meeting, please email angie.wright@issuerdirect.com.

Investors can register here for the conference.

About BIOLASE

BIOLASE is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. BIOLASE's products advance the practice of dentistry and medicine for patients and healthcare professionals. BIOLASE's proprietary laser products incorporate approximately 301 patented and 28 patent-pending technologies designed to provide biologically and clinically superior performance with less pain and faster recovery times. BIOLASE's innovative products provide cutting-edge technology at competitive prices to deliver superior results for dentists and patients. BIOLASE's principal products are revolutionary dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. From 1998 through December 31, 2021, BIOLASE has sold over 43,300 laser systems to date in over 80 countries around the world. Laser products under development address BIOLASE's core dental market and other adjacent medical and consumer applications.

For updates and information on Waterlase iPlus®, Waterlase Express™, and laser dentistry, find BIOLASE online at www.biolase.com, Facebook at www.facebook.com/biolase, Twitter at www.twitter.com/biolaseinc, Instagram at www.instagram.com/waterlase_laserdentistry, and LinkedIn at www.linkedin.com/company/biolase.

BIOLASE®, Waterlase® and Waterlase iPlus® are registered trademarks of BIOLASE, Inc.

For further information, please contact:

EVC Group LLC
Michael Polyviou / Todd Kehrli
(732) 933-2754
mpolyviou@evcgroup.com / tkehrli@evcgroup.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/biolase-to-present-at-the-third-annual-winter-wonderland-best-ideas-virtual-investor-conference-301749428.html

SOURCE BIOLASE, Inc.

FAQ

When will BIOLASE present at the Winter Wonderland Investor Conference?

BIOLASE will present on February 21, 2023, at 2:00 p.m. PT (5:00 p.m. ET).

What is the focus of BIOLASE's presentation at the conference?

The presentation will highlight BIOLASE's innovations in dental lasers and technology.

How can investors meet with BIOLASE management during the conference?

Investors can schedule one-on-one meetings with management from February 23-24, 2023.

Where can I watch the BIOLASE presentation online?

The presentation will be webcast live and available for replay at ir.biolase.com.

What technologies does BIOLASE focus on?

BIOLASE focuses on dental lasers, incorporating over 301 patented and 28 patent-pending technologies.